Bedogni B - Search Results

1

Wound Healing Assay for Melanoma Cell Migration.

Freitas JT, Jozic I, Bedogni B. Freitas JT, et al. Among authors: bedogni b. Methods Mol Biol. 2021;2265:65-71. doi: 10.1007/978-1-0716-1205-7_4. Methods Mol Biol. 2021. PMID: 33704705

2

Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma.

Marusak C, Thakur V, Li Y, Freitas JT, Zmina PM, Thakur VS, Chang M, Gao M, Tan J, Xiao M, Lu Y, Mills GB, Flaherty K, Frederick DT, Miao B, Sullivan RJ, Moll T, Boland GM, Herlyn M, Zhang G, Bedogni B. Marusak C, et al. Among authors: bedogni b. Clin Cancer Res. 2020 Nov 15;26(22):6039-6050. doi: 10.1158/1078-0432.CCR-19-2773. Epub 2020 Aug 20. Clin Cancer Res. 2020. PMID: 32820016 Free PMC article.

3

Hair(y) Matters in Melanoma Biology.

Bedogni B, Paus R. Bedogni B, et al. Trends Mol Med. 2020 May;26(5):441-449. doi: 10.1016/j.molmed.2020.02.005. Epub 2020 Apr 10. Trends Mol Med. 2020. PMID: 32359476 Review.

4

Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties.

Qiu H, Zmina PM, Huang AY, Askew D, Bedogni B. Qiu H, et al. Among authors: bedogni b. Cancer Lett. 2018 Oct 10;434:144-151. doi: 10.1016/j.canlet.2018.07.024. Epub 2018 Jul 21. Cancer Lett. 2018. PMID: 30036609 Free PMC article.

5

Blockade of CCR5 in melanoma: An alternative immune checkpoint modulator.

Escandon Brehm J, Bedogni B. Escandon Brehm J, et al. Among authors: bedogni b. Exp Dermatol. 2020 Feb;29(2):196. doi: 10.1111/exd.14065. Epub 2019 Dec 26. Exp Dermatol. 2020. PMID: 31785018

6

Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase.

Qiu H, Tang X, Ma J, Shaverdashvili K, Zhang K, Bedogni B. Qiu H, et al. Among authors: bedogni b. Mol Cell Biol. 2015 Nov;35(21):3622-32. doi: 10.1128/MCB.00116-15. Epub 2015 Aug 17. Mol Cell Biol. 2015. PMID: 26283728 Free PMC article.

7

The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.

Thakur V, Bedogni B. Thakur V, et al. Among authors: bedogni b. Pharmacol Res. 2016 Sep;111:17-22. doi: 10.1016/j.phrs.2016.05.019. Epub 2016 May 21. Pharmacol Res. 2016. PMID: 27221755 Review.

8

The membrane tethered matrix metalloproteinase MT1-MMP triggers an outside-in DNA damage response that impacts chemo- and radiotherapy responses of breast cancer.

Thakur V, Zhang K, Savadelis A, Zmina P, Aguila B, Welford SM, Abdul-Karim F, Bonk KW, Keri RA, Bedogni B. Thakur V, et al. Among authors: bedogni b. Cancer Lett. 2019 Feb 28;443:115-124. doi: 10.1016/j.canlet.2018.11.031. Epub 2018 Nov 29. Cancer Lett. 2019. PMID: 30502358 Free PMC article.

9

MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.

Shaverdashvili K, Zhang K, Osman I, Honda K, Jobava R, Bedogni B. Shaverdashvili K, et al. Among authors: bedogni b. Oncotarget. 2015 Oct 20;6(32):33512-22. doi: 10.18632/oncotarget.5258. Oncotarget. 2015. PMID: 26392417 Free PMC article.

10

The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.

Marusak C, Bayles I, Ma J, Gooyit M, Gao M, Chang M, Bedogni B. Marusak C, et al. Among authors: bedogni b. Pharmacol Res. 2016 Nov;113(Pt A):515-520. doi: 10.1016/j.phrs.2016.09.033. Epub 2016 Sep 26. Pharmacol Res. 2016. PMID: 27687955 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page